Digestive Disorders Associates (DDA) specializes in the diagnosis and treatment of adults and children with GI diseases and disorders. Our team of gastroenterologists has expertise in all types of digestive conditions, including acid reflux disease, Crohn’s and ulcerative colitis, IBS, swallowing disorders and hepatitis. Patients of DDA can choose to be seen in Annapolis, Chester, or Gambrills, Maryland.
As a smaller practice with three locations, our doctors are able to offer a more personalized, caring approach to their patients. During your initial consultation, your physician will listen patiently to your concerns. He or she will carefully review your GI symptoms and medical history. Finally, he or she will take time to carefully explain your initial diagnosis to help you understand the course of treatment that is recommended.
Sometimes your gastroenterologist will suggest additional testing (eg. colonoscopy, EGD, pillcam or motility testing) to confirm your GI diagnosis, and most often these can be scheduled in MDTEC, our private surgery center conveniently located in the Annapolis office.
The Annapolis office is also the location of our onsite infusion center. For GI disorders and diseases such as Crohn’s and ulcerative colitis or anemia, therapeutic infusions like Remicade, Entyvio and Injectafer are often recommended. DDA is the only gastroenterology practice in the area that offers an onsite infusion center for your comfort and privacy.
The physicians and staff of DDA work hard to provide our patients with the highest quality prevention and treatment of GI disease in a caring, compassionate manner. We are dedicated to providing each patient with superior medical treatment in a comfortable, safe atmosphere. Each patient’s care is managed by our impressive team of nationally recognized providers who are all leaders in the field of gastroenterology.
WHO WE ARE
What are you most excited about in the future of your field?
We are standing on the cusp of a new era of medical practice called precision medicine. We are working to bring these new tools to our practice and the future is looking bright. Instead of one drug or one treatment fits all; treatments will be individualized in order to optimize treatment. This will be based on an individual’s genetic content or molecular and cellular analysis. We will determine if you are at higher risk for certain cancers that we might screen for and prevent such as pancreatic and colon and ovarian. Medicine will shift from reaction to prevention and we will be able to improve disease detection and predict susceptibility to disease. We will be able to customize disease-prevention strategies and prescribe more effective drugs. We will avoid prescribing drugs with predictable negative side effects and eliminate the trial and error that we live with now.
What is it about digestive disorders that has kept you so intrigued all these years?
We never stop learning. I always feel like I have just begun to learn about a condition or a medical technique and something comes along that is newer and more advanced therapy and we are able to integrate that into the practice and help more people. We participate in medical research which allows us to offer the latest and best treatment and learn about new medical compounds.
Annapolis | Chester | Gambrills 410-224-4887 www.dda.net